Cytyc Corporation (CYTC) Acquisition Of Proxima Therapeutics Clears Antitrust Review
10/19/2005 5:12:51 PM
More...
|
Proxima Therapeutics Enters Into Agreement To Be Acquired By Cytyc Corporation (CYTC); $160 Million
10/19/2005 5:12:40 PM
More...
|
Proxima Therapeutics Partners With Nucletron B.V. To Introduce MammoSite Therapy For Breast Cancer In Australia And New Zealand
10/19/2005 5:12:21 PM
More...
|
Proxima Therapeutics Release: First Data On GliaSite Radiation Therapy System As Primary Treatment For Metastatic Brain Cancer Presented At Radiation Oncology Meeting
10/19/2005 5:11:45 PM
More...
|
Proxima Therapeutics Receives FDA Clearance For Next Generation MammoSite Device; State-Of-The-Art Catheters Will More Comfortably Deliver Targeted Internal Five-Day Radiation Therapy
10/19/2005 5:11:36 PM
More...
|
Proxima Therapeutics Receives US Patent For Device To Deliver Internal Radiation Therapy For Spinal Metastases
10/19/2005 5:11:35 PM
More...
|
Proxima Therapeutics Release: Study Indicates That MammoSite Offers Significant Advantages Over Conventional Radiation Boost Therapy For Breast Cancer
10/19/2005 5:11:18 PM
More...
|
Proxima Therapeutics Announces New Reimbursement Codes For MammoSite Radiation Therapy System
10/19/2005 5:10:52 PM
More...
|
Varian Medical Systems (VAR) And Proxima Therapeutics Form Alliance To Increase Access To Partial Breast Irradiation
10/19/2005 5:08:57 PM
More...
|